dacarbazine and glucagon

dacarbazine has been researched along with glucagon in 12 studies

Research

Studies (12)

Timeframe	Studies, this research(%)	All Research%
pre-1990	9 (75.00)	18.7374
1990's	2 (16.67)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (8.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Brłnstad, GO; Christoffersen, T; Haffner, F; Larsson, PG	1
Aoki, TT; Strauss, GM; Weitzman, SA	1
Totsuka, Y	1
Fujita, J; Horio, T; Imamura, S; Ishida, H; Matsukura, S; Naito, A; Seino, Y; Takahashi, K; Taminato, T; Tobe, T	1
Altimari, AF; Bhoopalam, N; Lange, CL; O'Dorsio, T; Prinz, RA; Sandberg, L	1
Benson, JB; Ferrara, JJ; Fucci, JC	1
Lefebvre, PJ; Luyckx, AS	1
Duncan, LA; Fagadau, WR; Marynick, SP	1
Awrich, AE; Fletcher, WS; Peetz, M	1
Badrinath, K; Banerji, M; Dorsch, TR; Lawrence, AM; Prinz, RA; Sparagana, M	1
Strohm, WD	1
Carilli, A; Pellini Ferreira, B; Vasquez, J	1

Reviews

1 review(s) available for dacarbazine and glucagon

Article	Year
[The glucagonomas (author's transl)]. Diabete & metabolisme, 1981, Volume: 7, Issue:4 Topics: Adenoma, Islet Cell; Adult; Aged; Amino Acids; Anemia; Arginine; Body Weight; Cholesterol; Dacarbazine; Diabetes Mellitus; Diagnosis, Differential; Erythema; Female; Glossitis; Glucagon; Glucagonoma; Humans; Hypoproteinemia; Male; Middle Aged; Nervous System Diseases; Pancreatic Neoplasms; Somatostatin; Streptozocin; Thrombophlebitis; Zinc	1981

Article

Year

[The glucagonomas (author's transl)].

Diabete & metabolisme, 1981, Volume: 7, Issue:4

Topics: Adenoma, Islet Cell; Adult; Aged; Amino Acids; Anemia; Arginine; Body Weight; Cholesterol; Dacarbazine; Diabetes Mellitus; Diagnosis, Differential; Erythema; Female; Glossitis; Glucagon; Glucagonoma; Humans; Hypoproteinemia; Male; Middle Aged; Nervous System Diseases; Pancreatic Neoplasms; Somatostatin; Streptozocin; Thrombophlebitis; Zinc

1981

Other Studies

11 other study(ies) available for dacarbazine and glucagon

Article	Year
The antitumour agent 5-(3,3-dimethyl-1-triazeno) imidazole-4-carboxamide (DTIC) inhibits rat liver cAMP phosphodiesterase and amplifies hormone effects in hepatocytes and hepatoma cells. British journal of cancer, 1979, Volume: 40, Issue:5 Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Cyclic AMP; Dacarbazine; Drug Synergism; Epinephrine; Glucagon; In Vitro Techniques; Liver; Liver Neoplasms, Experimental; Male; Rats; Theophylline	1979
Dimethyltriazenoimidazole carboxamide therapy of malignant glucagonoma. Annals of internal medicine, 1979, Volume: 90, Issue:1 Topics: Adult; Dacarbazine; Glucagon; Humans; Male; Pancreatic Neoplasms; Syndrome; Triazenes	1979
[Glucagonoma and somatostatinoma]. Nihon rinsho. Japanese journal of clinical medicine, 1991, Volume: 49 Suppl Topics: Dacarbazine; Female; Glucagon; Glucagonoma; Glucose; Humans; Liver; Middle Aged; Octreotide; Pancreatic Neoplasms; Somatostatinoma; Streptozocin	1991
A functional study of a case of glucagonoma exhibiting typical glucagonoma syndrome. Cancer, 1986, Feb-15, Volume: 57, Issue:4 Topics: Adenoma, Islet Cell; Arginine; Blood Glucose; Chromatography, Gel; Dacarbazine; Endocrine Glands; Gastric Inhibitory Polypeptide; Glucagon; Glucagonoma; Glucose Tolerance Test; Humans; Insulin; Male; Middle Aged; Pancreatic Neoplasms; Secretin; Somatostatin	1986
Use of a somatostatin analog (SMS 201-995) in the glucagonoma syndrome. Surgery, 1986, Volume: 100, Issue:6 Topics: Adenoma, Islet Cell; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Diabetes Mellitus; Drug Evaluation; Erythema; Female; Fluorouracil; Glucagon; Glucagonoma; Humans; Liver Neoplasms; Male; Middle Aged; Octreotide; Pancreatic Neoplasms; Somatostatin; Streptozocin; Syndrome	1986
Metastatic pancreatic islet cell carcinoma causing manifestations of glucagon and gastrin hypersecretion. Connecticut medicine, 1985, Volume: 49, Issue:12 Topics: Adenoma, Islet Cell; Dacarbazine; Gastrins; Glucagon; Humans; Male; Middle Aged; Neoplasm Metastasis; Pancreatic Neoplasms; Zollinger-Ellison Syndrome	1985
Malignant glucagonoma syndrome: response to chemotherapy. Annals of internal medicine, 1980, Volume: 93, Issue:3 Topics: Adenoma, Islet Cell; Dacarbazine; Female; Glucagon; Humans; Middle Aged; Pancreatic Neoplasms; Streptozocin; Syndrome	1980
Dimethyltriazenoimidazole carboxamide therapy of islet cell carcinoma of the pancreas. Journal of surgical oncology, 1981, Volume: 17, Issue:4 Topics: Adenoma, Islet Cell; Adult; Aged; Dacarbazine; Female; Glucagon; Humans; Male; Middle Aged; Pancreatic Neoplasms	1981
Operative and chemotherapeutic management of malignant glucagon-producing tumors. Surgery, 1981, Volume: 90, Issue:4 Topics: Adenoma, Islet Cell; Body Weight; Dacarbazine; Dermatitis; Diabetes Mellitus; Glucagon; Glucagonoma; Humans; Male; Middle Aged; Pancreatectomy; Pancreatic Neoplasms; Scotoma; Syndrome	1981
[Paraneoplastic spastic tetraparesis in glucagonoma syndrome. Successful therapy with octreotide, dacarbazine and interferon-alpha]. Zeitschrift fur Gastroenterologie, 1996, Volume: 34, Issue:7 Topics: Adult; Chemotherapy, Adjuvant; Combined Modality Therapy; Dacarbazine; Diagnostic Imaging; Glucagon; Glucagonoma; Humans; Interferon-alpha; Liver Neoplasms; Male; Octreotide; Pancreatectomy; Pancreatic Neoplasms; Paraneoplastic Syndromes; Quadriplegia	1996
Metastatic Hepatoid Carcinoma of the Pancreas: First Description of Treatment With Capecitabine and Temozolomide. The American journal of the medical sciences, 2017, Volume: 353, Issue:6 Topics: Adult; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Biopsy; Capecitabine; Carcinoma, Hepatocellular; Dacarbazine; Glucagon; Glucagonoma; Humans; Jaundice; Liver; Male; Neoplasm Metastasis; Pancreatic Neoplasms; Prognosis; Temozolomide; Treatment Outcome	2017